Skip to main content

Table 4 Single dose adults—antibodies (log10 mIU/mL)—by time interval

From: Validation of a yellow fever vaccine model using data from primary vaccination in children and adults, re-vaccination and dose-response in adults and studies with immunocompromised individuals

Categorical time

Number of individuals

Average time (days)

GMT (\(\text {log}_{10}\) mIU/mL)

NV (0)

46

0

1.96

PV (30–45 days)

46

44 (42–49)

3.88

PV (1–5 years)

36

1367 (537–1833)

3.40

PV (5–9 years)

12

2609 (1882–3406)

3.40

PV (> 10 years)

45

4081 (3721–4414)

3.19